of this conference are (a) a better awareness of these diseases in the
hematology, oncology, and infectious disease community; (b) a working
definition of these diseases; and (c) a framework for investigating the
cause and treatment of these disorders. It is hoped that new clinical
protocols will be developed to treat these diseases and that possibly a
consortium will be organized.
Epstein-Barr Virus Lymphoproliferative Disease in non-immunosuppressed hosts